Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 Park Street
New Haven, CT 06510Phone+1 617-632-6876Fax+1 617-632-1930
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987- Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
Yale School of MedicineClass of 1983
Certifications & Licensure
ME State Medical License Current
CT State Medical License 2021 - 2024
MA State Medical License 1997 - 2023
NC State Medical License 1987 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases Start of enrollment: 2004 Oct 01
- Educational Interventions for Patients With DCIS Start of enrollment: 2003 May 01
- Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 259 citationsSystemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Gu...Sharon H. Giordano, Sarah Temin, Jeffrey J. Kirshner, Sarat Chandarlapaty, Jennie R. Crews
Journal of Clinical Oncology. 2014-05-05 - 89 citationsEffect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A R...Sara M. Tolaney, Romualdo Barroso-Sousa, Tanya Keenan, Tianyu Li, Lorenzo Trippa
JAMA Oncology. 2020-10-01 - 921 citationsCDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J. DeCristo, April C. Watt, Haley BrinJones, Jaclyn Sceneay
Nature. 2017-08-24
Journal Articles
- Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast CancerEric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
- Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerSara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
- Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 StudyM C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
- Join now to see all
Lectures
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/11/2013
- 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS)UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/12/2012
Press Mentions
Dr. Cary Gross on Yale Cancer Answers: Health Equity and Cancer PreventionOctober 7th, 2024- Breast Cancer Survivor Encourages Early TestingOctober 1st, 2024
- Breast Cancer Mortality Rates Higher for Black Women Across All Types Compared to White Women – New StudySeptember 19th, 2024
- Join now to see all
Grant Support
- Clinical Studies CoreNational Cancer Institute2008–2009
- Cancer And Leukemia Group BNational Cancer Institute2006–2008
- C-2: Clinical Study CoreNational Cancer Institute2005–2007
- Psychosocial Outcomes/Health Behaviors: Women With DCISNational Cancer Institute2000–2002
- Tailored Information Materials About BRCA1 TestingNational Cancer Institute1995–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
